News Releases
2023 NEWS RELEASES
XTCY Announces A Management Cease Trade Order
Vancouver January 30, 2024 – XTACY THERAPEUTICS CORP. (CSE: XTCY) (Frankfurt: O3X4) (OTCQB: XTCYF) (“Xtacy Therapeutics” or the “Company”) announces today a Management Cease
XTACY Therapeutics Expands MDMA Platform
Vancouver December 5th, 2023 – Xtacy Therapeutics Corp. (CSE: XTCY) (Frankfurt: O3X4) (OTCQB: XTCYF) (“the Company) announces expansion of its MDMA research platform to help
Voting Instruction Form (“VIF”) – Annual General Meeting to be held on Wednesday, August 16, 2023
NON-REGISTERED (BENEFICIAL) SECURITYHOLDERS We are sending to you the enclosed proxy-related materials that relate to a meeting of the holders of the series or class
2022 NEWS RELEASES
2021 NEWS RELEASES
Global Wellness Introduces KaleidoMyco’s Trifecta Powder-In-Capsule
Vancouver, British Columbia, March 31, 2021– Global Wellness Strategies Inc. (formerly Redfund Capital Corp.)(CSE: LOAN) (Frankfurt:O3X4) (OTC QB: PNNRF) (“Global” or the “Company”) introduces KaleidoMyco’s
Global Wellness Strategies Unveils First New Product for KaleidoUSA
Vancouver, British Columbia, March 4, 2021 – Global Wellness Strategies Inc. (formerly Redfund Capital Corp.)(CSE: LOAN) (Frankfurt:O3X4) (OTC QB: PNNRF) (“Global” or the “Company”) unveils
Global Wellness Strategies Announces Acquisition of KaleidoUSA Myco-Dosing Innovator
Vancouver, British Columbia, February 26, 2021– Global Wellness Strategies Inc. (formerly Redfund Capital Corp.)(CSE: LOAN) (Frankfurt:O3X4) (OTC QB: PNNRF) (“Global” or the “Company”) announces it